Don’t just take my word for it…
Heather interacts closely with our team and helps enormously in guiding our efforts toward the machine learning architectures that perform best for our system. Her deep understanding of the diverse range of ML architectures and capabilities allows us focus on the data preprocessing, data augmentation, and validation techniques that produce the most robust results given our unique data and challenges.
-- Alan Kersey, CytoVeris, President & CEO
Our team was fortunate to work with Heather on a short-term project, where she was a critical contributor to establishing a framework for future studies. She has an unusual ability to demystify, in plain language, new developments in computer science for a wide audience, and I am confident through her work she will influence many teams and help bring to reality the next set of tools to transform pathology.
-- Keith Wharton, Ultivue, VP Medical Director
Heather has accelerated the development of our machine learning projects by challenging the status quo and introducing the team to new approaches. She helped us get out of the echo chamber and brought an outside perspective with very relevant alternative approaches that would have taken a lot longer to do on our own.
-- Joe Sturonas, Ancera, VP of Systems Development
Pixel Scientia provides valuable insights for Gestalt's image analysis product development. Heather has deep understanding of digital pathology and machine learning and their application to whole slide images. Her in-depth review of the current state of the art research has enabled Gestalt to rapidly focus our machine learning efforts on approaches that are yielding value for our pathologists and their patients.
-- Brian Napora, Gestalt Diagnostics, VP of Sales & Product Management
Heather's knowledge of the current state of the art within the digital pathology field is second to none. Consultation on best practice approaches for deep learning model classification performance and insight into digital research perspectives were very beneficial. Discussions of prior art enabled our team to focus on novel research and refine our current AI methodologies for clinical research.
-- Jenny Fitzgerald, Deciphex, Director of Clinical Research & Operations